Cargando…

The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422532/
https://www.ncbi.nlm.nih.gov/pubmed/28496341
http://dx.doi.org/10.2147/OTT.S140498
_version_ 1783234799944597504
collection PubMed
description
format Online
Article
Text
id pubmed-5422532
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-54225322017-05-11 The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction] Onco Targets Ther Retraction Dove Medical Press 2017-05-04 /pmc/articles/PMC5422532/ /pubmed/28496341 http://dx.doi.org/10.2147/OTT.S140498 Text en © 2017 Dove Medical Press. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Retraction
The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]
title The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]
title_full The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]
title_fullStr The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]
title_full_unstemmed The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]
title_short The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]
title_sort coexpression of ephb4 and ephrinb2 is associated with poor prognosis in her2-positive breast cancer [retraction]
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422532/
https://www.ncbi.nlm.nih.gov/pubmed/28496341
http://dx.doi.org/10.2147/OTT.S140498